| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $489.7M | +19.1% |
| Cost of Revenue | $102.8M | +14.9% |
| Gross Profit | $386.9M | +20.3% |
| R&D Expense | $101.2M | +24.5% |
| SG&A Expense | $58.0M | -24.0% |
| Operating Income | $130.5M | +48.9% |
| Interest Expense | $0 | — |
| Pre-tax Income | $133.7M | +49.6% |
| Income Tax | $25.7M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $173.7M | +26.5% |
| Accounts Receivable | $121.8M | +11.7% |
| Current Assets | $473.3M | -13.4% |
| Total Assets | $700.9M | -13.9% |
| Current Liabilities | $352.2M | +15.7% |
| Total Liabilities | $411.8M | +9.0% |
| Stockholders' Equity | $289.1M | -33.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $198.9M | -0.9% |
| Capital Expenditures | $15.4M | -37.1% |
| Investing Cash Flow | $145.1M | +591.2% |
| Financing Cash Flow | -$306.0M | -183.7% |
| Free Cash Flow | $183.5M | +4.1% |
| +39.4% |
| Net Income | $108.0M | +52.2% |
| EPS (Basic) | $2.81 | +54.4% |
| EPS (Diluted) | $2.74 | +54.8% |